Neuroprotective effect of Kampo medicine against brain ischemia and its mode of action
Neuroprotective effect of Kampo medicine against brain ischemia and its mode of action
批准号:
16590556
负责人:
SHIMADA Yutaka
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006
中文摘要
以前,我们已经revealed that chotosan (Diao-teng-san), a Kampo formula,is effective on vascular dementia clinically, and the hooks and stems of Uncaria sinensis,一个医疗植物comprising chotosan,has a neuroproteve effect in vitro. For the purpose of clarifying their effects in vivo,我们investigated whether the oral administration of chotosan extract (CSE) or Uncaria sinensisextract (USE) reduces delayed neuronal death of pyramidal cells in the hippocampus followingischemia/reperfusion (i/rp) in gerbils. CSE or USE dissolved in drinking water and provided tothe gerbils ad libitum from 7 days prior to i/rp until 7 days after i/rp. It was found that CSE-orUSE-treatments significantly reduced pyramidal cell death in the hippocampal CA1 region at 7 daysafter i/rp. Lipid peroxide (LPO) and nitrite (no_2 ^-)/nitrate (no_3 ^-) levels of the hippocampus at48hr after i/rp in the CSE- or USE-treated groups were significantly lower than those of control.Superoxide anion (o_2 ^-) and hydroxyl radical (HO) scavenging activities in both the hippocampusand cortex without i/rp, and also at 3 hours and 7 days after i/rp,were enhanced by the administration of CSE or USE. Administrations of CSE or USE without i/rpprocedure enhanced catalase (CAT) activity but superoxide dismutase (SOD) and glutathioneperoxidase (GSH-Px) activities in the both the hippocampus and cortex. CSE elevated CAT activity in thehippocampus at 7 days and that in the cortex at 3 hours after i/rp. USE raised CAT activity in boththe hippocampus and cortex at 3小时7天after i/rp. These results suggest that the oraladministrations of CSE and USE provide a protective effect against transient ischemi -induceddelayed neuronal death by reducing oxidative damage to neuronsand one of the mechanisms may be their增强猫activity in the brain的效果。
英文摘要
Previously, we have revealed that chotosan (Diao-teng-san), a Kampo formula, is effective on vascular dementia clinically, and the hooks and stems of Uncaria sinensis, a medicinal plant comprising chotosan, has a neuroprotective effect in vitro. For the purpose of clarifying their effects in vivo, we investigated whether the oral administration of chotosan extract (CSE) or Uncaria sinensis extract (USE) reduces delayed neuronal death of pyramidal cells in the hippocampus following ischemia/reperfusion (i/rp) in gerbils. CSE or USE were dissolved in drinking water and provided to the gerbils ad libitum from 7 days prior to i/rp until 7 days after i/rp. It was found that CSE-or USE-treatments significantly reduced pyramidal cell death in the hippocampal CA1 region at 7 days after i/rp. Lipid peroxide (LPO) and nitrite (NO_2^-)/nitrate (NO_3^-) levels of the hippocampus at 48 hr after i/rp in the CSE- or USE-treated groups were significantly lower than those of control. Superoxide anion (O_2^-・) and hydroxyl radical (HO・) scavenging activities in both the hippocampus and cortex without i/rp, and also at 3 hours and 7 days after i/rp, were enhanced by the administration of CSE or USE. Administrations of CSE or USE without i/rp procedure enhanced catalase (CAT) activity but not superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities in both the hippocampus and cortex. CSE elevated CAT activity in the hippocampus at 7 days and that in the cortex at 3 hours after i/rp. USE raised CAT activity in both the hippocampus and cortex at 3 hours and 7 days after i/rp. These results suggest that the oral administrations of CSE and USE provide a protective effect against transient ischemia-induced delayed neuronal death by reducing oxidative damage to neurons, and one of the mechanisms may be their enhancing effect on CAT activity in the brain.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Chotosan and cerebrovascular disorders : clinical and experimental studies
Chotosan 和脑血管疾病:临床和实验研究
DOI:
--
发表时间:
2006
期刊:
Journal of Traditional Medicines Vol.23
影响因子:
--
作者:
[Yutaka Shimada, et al.]
通讯作者:
et al.
DOI:
10.1016/j.phymed.2003.04.001
发表时间:
2004-09-01
期刊:
PHYTOMEDICINE
影响因子:
7.9
作者:
[Yokoyama, K, Shimada, Y, Terasawa, K]
通讯作者:
Terasawa, K
DOI:
10.1016/j.jep.2004.08.018
发表时间:
2004-12-01
期刊:
JOURNAL OF ETHNOPHARMACOLOGY
影响因子:
5.4
作者:
[Yokoyama, K, Shimada, Y, Terasawa, K]
通讯作者:
Terasawa, K
Chotosan and cerebrovascular disorders : clinical and experimental studies.
Chotosan 和脑血管疾病:临床和实验研究。
DOI:
--
发表时间:
2006
期刊:
Journal of Traditional Medicines 23巻
影响因子:
--
作者:
[Yutaka Shimada, Hirozo Goto, Katsutoshi Terasawa]
通讯作者:
Katsutoshi Terasawa
Research on the treatment of esophageal cancer with anti-human fibroblast growth factor receptor like-1
-
批准号:26293302
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.4万
-
财政年份:2014
-
负责人:SHIMADA Yutaka
-
依托单位:
Detection of gastrointestinal cancer biomarkers by next-generation mass spectrometry and comprehensive gene expression analysis
-
批准号:23390320
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2011
-
负责人:SHIMADA Yutaka
-
依托单位:
Protective effect of Kampo medicine on vascular endothelial functionin patients with metabolic syndrome
-
批准号:22590649
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2010
-
负责人:SHIMADA Yutaka
-
依托单位:
Research for the establishment of pluripotent stem cells from normal human culture cells and tissue engineering
-
批准号:22659228
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.04万
-
财政年份:2010
-
负责人:SHIMADA Yutaka
-
依托单位:
The expression and function of microRNA in esophageal cancer cells and normal esophageal epithelial cells
-
批准号:19390356
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2007
-
负责人:SHIMADA Yutaka
-
依托单位:
Research for esophageal carcinogenesis and proliferation, by characterization of cancer stem cells and analysis of the inactivation mechanism for suppressor genes in normal esophageal epithelial cells.
-
批准号:17390363
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.79万
-
财政年份:2005
-
负责人:SHIMADA Yutaka
-
依托单位:
ELECTROMAGNETIC PROPERTIES AND APPLICATION TO MICRO-EMC OF THE METAL-OXIDE COMPOSITE FILMS WITH A FIBER LIKE NANO-STRUCTURE
-
批准号:15360158
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.54万
-
财政年份:2003
-
负责人:SHIMADA Yutaka
-
依托单位:
Research for esophageal carcinogenesis and differentiation induction therapy based on normal esophageal epithelial cells and esophageal stem cells
-
批准号:14370385
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.47万
-
财政年份:2002
-
负责人:SHIMADA Yutaka
-
依托单位:
Construction of educational global standardin Kampo Medicine
-
批准号:13470502
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.25万
-
财政年份:2001
-
负责人:SHIMADA Yutaka
-
依托单位:
Molecular analysis and application of differentiation induction therapy with intra-nuclear receptor and intra-cellular signal transduction factor
-
批准号:12470259
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.59万
-
财政年份:2000
-
负责人:SHIMADA Yutaka
-
依托单位:
Growth arrest signal in esophageal cancer. Biological significance and clinical implication of EGF-STAT signal transduction system.
-
批准号:10470241
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.3万
-
财政年份:1998
-
负责人:SHIMADA Yutaka
-
依托单位:
Fundamental study on gene therapy for diseased myocardium by introduction of myogenetic genes into fibroblasts
-
批准号:10557001
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.63万
-
财政年份:1998
-
负责人:SHIMADA Yutaka
-
依托单位:
Gene expression of muscle proteins and molecular mechanisms of contractile structure formation
-
批准号:09670002
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:SHIMADA Yutaka
-
依托单位:
Synthesis of metal alloy particles with high magnetic surface anisotropy and development of new functions
-
批准号:09450231
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:1997
-
负责人:SHIMADA Yutaka
-
依托单位:
Research on the prediction of hematogenous metastasis and recurrence of hepatocellular carcinoma, pancreatic carcinoma, gastric carcinoma and esophageal carcinoma. (Detection of circulating AFPmRNA,CEAmRNA and Cytokeratin mRNA)
-
批准号:09671301
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:SHIMADA Yutaka
-
依托单位:
SYNTHESIS PROCESS AND GIANT MAGNETIZATION OF INTERSTITIAL TYPE (Fe、Co)-(B、C、N) SINGLE CRYSTALS
-
批准号:07455273
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.54万
-
财政年份:1995
-
负责人:SHIMADA Yutaka
-
依托单位:
Analysis of Cell Cycle Related Gene and Cell Culture in Esophageal Cancer. (Carcinogenesis, Tumor Progression and Prognostic Factor)
-
批准号:07671386
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1995
-
负责人:SHIMADA Yutaka
-
依托单位:
Cardiac morphogenesis and myofibrillogenesis
-
批准号:06044037
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$5.25万
-
财政年份:1994
-
负责人:SHIMADA Yutaka
-
依托单位:
Molecular and cellular biology of dynamics and mechanisms of myofibrillogenesis
-
批准号:06670010
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1994
-
负责人:SHIMADA Yutaka
-
依托单位:
Regeneration of muscle fibers after myoblast injection into dystrophic muscle
-
批准号:05557001
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$5.25万
-
财政年份:1993
-
负责人:SHIMADA Yutaka
-
依托单位:
海外基金